Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 5Endometrial Neoplasms 5Uterine Cervical Neoplasms 2Neoplasms 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms by Site 1Low Grade Serous Ovarian Cancer 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Granulosa Cell Ovarian Cancer 1Fallopian Tube Neoplasms 1Endometrial Stromal Tumors 1Carcinoma 1Breast Diseases 1

Interventions

Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Granulosa Cell Ovarian Cancer × Anastrozole × Gynecologic × Clear all
NCT03909152 2025-07-28

A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
34 enrolled 9 charts
Gynecologic

Granulosa Cell Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡